A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 219M | 167M | 143M | 36M |
| Net Income | -35M | -35M | -50M | -25M | -27M | -6.4M |
| EPS | $0.00 | $0.00 | $-0.65 | $-0.36 | $-0.55 | $-0.23 |
| Free Cash Flow | -1.4M | -1.4M | -594K | -23M | 556K | -5.3M |
| ROIC | -10.9% | -5.2% | - | -1.8% | -2.5% | - |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.91 | 0.81 | 0.79 | 0.80 | 1.24 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -35M | -35M | - | -14M | -18M | - |
| Operating Margin | 0.0% | - | - | -8.4% | -12.4% | - |
| ROE | -12.6% | -12.6% | -15.8% | -7.0% | -8.5% | -7.8% |
| Shares Outstanding | 0M | 0M | 76M | 69M | 50M | 28M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 36M | 143M | 167M | 219M | 0 | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | N/A | -18M | -14M | N/A | -35M | -35M |
| Op. Margin | N/A | -12.4% | -8.4% | N/A | N/A | 0.0% |
| Net Income | -6.4M | -27M | -25M | -50M | -35M | -35M |
| Net Margin | -17.7% | -19.2% | -14.8% | -22.8% | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | N/A | -2.5% | -1.8% | N/A | -5.2% | -10.9% |
| ROE | -7.8% | -8.5% | -7.0% | -15.8% | -12.6% | -12.6% |
| ROA | -3.1% | -4.1% | -3.3% | -7.3% | -5.5% | -5.5% |
| Cash Flow | ||||||
| Op. Cash Flow | -1.6M | 5.5M | -16M | 6.2M | 3.2M | 3.2M |
| Free Cash Flow | -5.3M | 556K | -23M | -594K | -1.4M | -1.4M |
| Owner Earnings | -8.5M | -19M | -44M | -26M | -28M | -28M |
| CapEx | 3.7M | 5.0M | 7.1M | 6.8M | 4.6M | 4.6M |
| Maint. CapEx | 6.9M | 25M | 27M | 32M | 31M | 31M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 6.9M | 25M | 27M | 32M | 31M | 31M |
| CapEx/OCF | N/A | 90.0% | N/A | 109.6% | 141.7% | 141.7% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 193K | 149K | 479K | 312K | 29K | 29K |
| Buyback Yield | 0.1% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 2.8M | 109M | 31M | 3.0M | 8.5M | 8.5M |
| Balance Sheet | ||||||
| Net Debt | 61M | 218M | 245M | 210M | 228M | -22M |
| Cash & Equiv. | 40M | 41M | 36M | 45M | 22M | 22M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 1.24 | 0.80 | 0.79 | 0.81 | 0.91 | 0.00 |
| Interest Coverage | N/A | -1.5 | -0.9 | N/A | N/A | N/A |
| Equity | 82M | 323M | 354M | 315M | 274M | 274M |
| Total Assets | 208M | 667M | 741M | 683M | 631M | 631M |
| Total Liabilities | 126M | 344M | 387M | 368M | 358M | 358M |
| Intangibles | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital | 18M | 37M | 1.4M | -3.0M | -11M | -11M |
| Current Assets | 43M | 122M | 107M | 110M | 96M | 96M |
| Current Liabilities | 25M | 84M | 106M | 113M | 108M | 108M |
| Per Share Data | ||||||
| EPS | -0.23 | -0.55 | -0.36 | -0.65 | 0.00 | 0.00 |
| Owner EPS | -0.30 | -0.38 | -0.63 | -0.34 | N/A | N/A |
| Book Value | 2.90 | 6.43 | 5.13 | 4.12 | 0.00 | 0.00 |
| Cash Flow/Share | 0.02 | -0.06 | 0.04 | -0.23 | 0.00 | 0.00 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | 28.3M | 50.3M | 69.0M | 76.4M | 0.0M | 0.0M |
| Valuation | ||||||
| P/E Ratio | -45.2 | -20.9 | -17.4 | -6.2 | N/A | N/A |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 3.5 | 1.8 | 1.2 | 1.0 | N/A | N/A |
| Price/Sales | 8.0 | 4.0 | 2.6 | 1.4 | N/A | N/A |
| FCF Yield | -1.8% | 0.1% | -5.5% | -0.2% | N/A | N/A |
| Market Cap | 288M | 573M | 428M | 310M | 0 | 0 |
| Avg. Price | 7.38 | 11.58 | 7.72 | 5.33 | 3.61 | 2.95 |
| Year-End Price | 10.18 | 11.38 | 6.20 | 4.06 | 3.68 | 2.95 |
ATRYS HEALTH, S.A. passes 0 of 9 quality checks, indicating weak fundamentals.
ATRYS HEALTH, S.A. (ATRY-MC) has a 5-year average return on invested capital (ROIC) of -3.1%. This is below average and may indicate limited pricing power.
ATRYS HEALTH, S.A. (ATRY-MC) does not currently pay a regular dividend.
ATRYS HEALTH, S.A. (ATRY-MC) generated $-1 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
ATRYS HEALTH, S.A. (ATRY-MC) has a debt-to-equity ratio of 0.91. This indicates moderate leverage.
ATRYS HEALTH, S.A. (ATRY-MC) has a return on equity (ROE) of -12.6%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 5 years of financial data for ATRYS HEALTH, S.A. (ATRY-MC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.